Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Joel Lexchin, Professor Emeritus of Health Policy and Management, York University, Canada

Canada’s new drug pricing guidelines are industry-friendly

Drug pricing in Canada just got more industry-friendly.

Canadian drug prices are already the fourth highest in the industrialized world. Now, with the release of new guidelines for the staff at the Patented Medicine Prices Review Board (PMPRB) at the end of June, the situation is poised to potentially get even worse.

The review board is the federal agency that was set up 1987 to ensure that the prices for patented drugs are not “excessive.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.